首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Inducing endogenous antimicrobial peptides to battle infections
【24h】

Inducing endogenous antimicrobial peptides to battle infections

机译:诱导内源性抗菌肽抵抗感染

获取原文
获取原文并翻译 | 示例
       

摘要

If asked how we currently treat a bacterial infection such as Shigella dysentery, most informed individuals would offer that we administer antibiotics. Our informed individual would add that we must also restore the losses of water and salts leaving the body as diarrhea, most likely with an appropriately designed "oral rehydra-tion" solution. But to halt the infection itself, surely we must either treat shigel-losis with antibiotics or let the infection run its course. By "run its course," we mean simply that if we can hold off giving antibiotics long enough, the adaptive immune system will eventually assemble the macrophages, lymphocytes, and antibodies capable of fighting off this organism. Unfortunately, many children die waiting for the "sluggish" adaptive immune system to do its thing. Furthermore, overuse of antibiotics has resulted in the emergence of drug-resistant strains of Shigella in countries besieged with dysentery (1).
机译:如果被问及我们目前如何治疗细菌性感染,例如志贺氏菌痢疾,大多数知情的人都会提出我们要使用抗生素。我们的知情人士会补充说,我们还必须恢复腹泻引起的水分和盐分流失,这很可能是通过适当设计的“口服补液”解决方案进行的。但是,要制止感染本身,我们当然必须要么用抗生素治疗志贺氏病,要么让感染顺利进行。所谓“顺其自然”,是指如果我们能够坚持给予抗生素足够长的时间,那么适应性免疫系统将最终组装能够抵抗这种生物的巨噬细胞,淋巴细胞和抗体。不幸的是,许多孩子死于等待“迟钝”的适应性免疫系统完成其任务。此外,抗生素的过度使用导致痢疾困扰的国家出现了志贺氏菌耐药菌株(1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号